ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Grade Eribulin Mesylate Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-25I14288
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Grade Eribulin Mesylate Market Research Report 2023
BUY CHAPTERS

Global Pharmaceutical Grade Eribulin Mesylate Market Research Report 2025

Code: QYRE-Auto-25I14288
Report
February 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Natco Pharma Ltd
Emcure Pharmaceuticals Ltd.
Dr. Reddys Laboratories Ltd.
Wisdom Pharmaceutical Co., Ltd.
Formosa Laboratories, Inc
Brightgene Bio-Medical Technology Co Ltd
Eurofins Cdmo Alphora Inc
Xiling Lab Co Ltd
Chongqing Sintaho Pharmaceutical Co Ltd
Lianyungang Runzhong Pharmaceutical Co Ltd
Zhejiang Raybow Pharmaceutical Co Ltd

Pharmaceutical Grade Eribulin Mesylate Market Size

The global market for Pharmaceutical Grade Eribulin Mesylate was valued at US$ 428 million in the year 2024 and is projected to reach a revised size of US$ 582 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Pharmaceutical Grade Eribulin Mesylate Market

Pharmaceutical Grade Eribulin Mesylate Market

Pharmaceutical Grade Eribulin Mesylate is a significant drug in the field of oncology, mainly used for the treatment of certain cancers. It is derived from a natural product and acts as a microtubule dynamics inhibitor, which means it interferes with the normal process of cell division, ultimately leading to cancer cell death.
Eribulin is typically used in patients who have previously received other treatments and may be given intravenously. It is important for healthcare professionals to monitor patients for potential side effects, which can include fatigue, nausea, and changes in blood cell counts, among others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Eribulin Mesylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Eribulin Mesylate.
The Pharmaceutical Grade Eribulin Mesylate market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Grade Eribulin Mesylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Grade Eribulin Mesylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pharmaceutical Grade Eribulin Mesylate Market Report

Report Metric Details
Report Name Pharmaceutical Grade Eribulin Mesylate Market
Accounted market size in year US$ 428 million
Forecasted market size in 2031 US$ 582 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Purity≥99%
  • Purity<99%
Segment by Application
  • Solution
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Natco Pharma Ltd, Emcure Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Wisdom Pharmaceutical Co Ltd, Formosa Laboratories Inc, Eurofins Cdmo Alphora Inc, Xiling Lab Co Ltd, Chongqing Sintaho Pharmaceutical Co Ltd, Lianyungang Runzhong Pharmaceutical Co Ltd, Zhejiang Raybow Pharmaceutical Co Ltd, Brightgene Bio-Medical Technology Co Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pharmaceutical Grade Eribulin Mesylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pharmaceutical Grade Eribulin Mesylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pharmaceutical Grade Eribulin Mesylate Market growing?

Ans: The Pharmaceutical Grade Eribulin Mesylate Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Pharmaceutical Grade Eribulin Mesylate Market size in 2031?

Ans: The Pharmaceutical Grade Eribulin Mesylate Market size in 2031 will be US$ 582 million.

Who are the main players in the Pharmaceutical Grade Eribulin Mesylate Market report?

Ans: The main players in the Pharmaceutical Grade Eribulin Mesylate Market are Natco Pharma Ltd, Emcure Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Wisdom Pharmaceutical Co Ltd, Formosa Laboratories Inc, Eurofins Cdmo Alphora Inc, Xiling Lab Co Ltd, Chongqing Sintaho Pharmaceutical Co Ltd, Lianyungang Runzhong Pharmaceutical Co Ltd, Zhejiang Raybow Pharmaceutical Co Ltd, Brightgene Bio-Medical Technology Co Ltd

What are the Application segmentation covered in the Pharmaceutical Grade Eribulin Mesylate Market report?

Ans: The Applications covered in the Pharmaceutical Grade Eribulin Mesylate Market report are Solution, Others

What are the Type segmentation covered in the Pharmaceutical Grade Eribulin Mesylate Market report?

Ans: The Types covered in the Pharmaceutical Grade Eribulin Mesylate Market report are Purity≥99%, Purity<99%

1 Pharmaceutical Grade Eribulin Mesylate Market Overview
1.1 Product Definition
1.2 Pharmaceutical Grade Eribulin Mesylate by Type
1.2.1 Global Pharmaceutical Grade Eribulin Mesylate Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Pharmaceutical Grade Eribulin Mesylate by Application
1.3.1 Global Pharmaceutical Grade Eribulin Mesylate Market Value by Application (2024 VS 2031)
1.3.2 Solution
1.3.3 Others
1.4 Global Pharmaceutical Grade Eribulin Mesylate Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Grade Eribulin Mesylate Revenue 2020-2031
1.4.2 Global Pharmaceutical Grade Eribulin Mesylate Sales 2020-2031
1.4.3 Global Pharmaceutical Grade Eribulin Mesylate Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pharmaceutical Grade Eribulin Mesylate Market Competition by Manufacturers
2.1 Global Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pharmaceutical Grade Eribulin Mesylate Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pharmaceutical Grade Eribulin Mesylate, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Grade Eribulin Mesylate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Grade Eribulin Mesylate, Product Type & Application
2.7 Global Key Manufacturers of Pharmaceutical Grade Eribulin Mesylate, Date of Enter into This Industry
2.8 Global Pharmaceutical Grade Eribulin Mesylate Market Competitive Situation and Trends
2.8.1 Global Pharmaceutical Grade Eribulin Mesylate Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pharmaceutical Grade Eribulin Mesylate Players Market Share by Revenue
2.8.3 Global Pharmaceutical Grade Eribulin Mesylate Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharmaceutical Grade Eribulin Mesylate Market Scenario by Region
3.1 Global Pharmaceutical Grade Eribulin Mesylate Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pharmaceutical Grade Eribulin Mesylate Sales by Region: 2020-2031
3.2.1 Global Pharmaceutical Grade Eribulin Mesylate Sales by Region: 2020-2025
3.2.2 Global Pharmaceutical Grade Eribulin Mesylate Sales by Region: 2026-2031
3.3 Global Pharmaceutical Grade Eribulin Mesylate Revenue by Region: 2020-2031
3.3.1 Global Pharmaceutical Grade Eribulin Mesylate Revenue by Region: 2020-2025
3.3.2 Global Pharmaceutical Grade Eribulin Mesylate Revenue by Region: 2026-2031
3.4 North America Pharmaceutical Grade Eribulin Mesylate Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Grade Eribulin Mesylate Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pharmaceutical Grade Eribulin Mesylate Sales by Country (2020-2031)
3.4.3 North America Pharmaceutical Grade Eribulin Mesylate Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Grade Eribulin Mesylate Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Grade Eribulin Mesylate Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pharmaceutical Grade Eribulin Mesylate Sales by Country (2020-2031)
3.5.3 Europe Pharmaceutical Grade Eribulin Mesylate Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Grade Eribulin Mesylate Market Facts & Figures by Region
3.6.1 Asia Pacific Pharmaceutical Grade Eribulin Mesylate Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pharmaceutical Grade Eribulin Mesylate Sales by Region (2020-2031)
3.6.3 Asia Pacific Pharmaceutical Grade Eribulin Mesylate Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Grade Eribulin Mesylate Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Grade Eribulin Mesylate Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pharmaceutical Grade Eribulin Mesylate Sales by Country (2020-2031)
3.7.3 Latin America Pharmaceutical Grade Eribulin Mesylate Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Grade Eribulin Mesylate Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Grade Eribulin Mesylate Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pharmaceutical Grade Eribulin Mesylate Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pharmaceutical Grade Eribulin Mesylate Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Grade Eribulin Mesylate Sales by Type (2020-2031)
4.1.1 Global Pharmaceutical Grade Eribulin Mesylate Sales by Type (2020-2025)
4.1.2 Global Pharmaceutical Grade Eribulin Mesylate Sales by Type (2026-2031)
4.1.3 Global Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Type (2020-2031)
4.2 Global Pharmaceutical Grade Eribulin Mesylate Revenue by Type (2020-2031)
4.2.1 Global Pharmaceutical Grade Eribulin Mesylate Revenue by Type (2020-2025)
4.2.2 Global Pharmaceutical Grade Eribulin Mesylate Revenue by Type (2026-2031)
4.2.3 Global Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Type (2020-2031)
4.3 Global Pharmaceutical Grade Eribulin Mesylate Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pharmaceutical Grade Eribulin Mesylate Sales by Application (2020-2031)
5.1.1 Global Pharmaceutical Grade Eribulin Mesylate Sales by Application (2020-2025)
5.1.2 Global Pharmaceutical Grade Eribulin Mesylate Sales by Application (2026-2031)
5.1.3 Global Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Application (2020-2031)
5.2 Global Pharmaceutical Grade Eribulin Mesylate Revenue by Application (2020-2031)
5.2.1 Global Pharmaceutical Grade Eribulin Mesylate Revenue by Application (2020-2025)
5.2.2 Global Pharmaceutical Grade Eribulin Mesylate Revenue by Application (2026-2031)
5.2.3 Global Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Application (2020-2031)
5.3 Global Pharmaceutical Grade Eribulin Mesylate Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Natco Pharma Ltd
6.1.1 Natco Pharma Ltd Company Information
6.1.2 Natco Pharma Ltd Description and Business Overview
6.1.3 Natco Pharma Ltd Pharmaceutical Grade Eribulin Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Natco Pharma Ltd Pharmaceutical Grade Eribulin Mesylate Product Portfolio
6.1.5 Natco Pharma Ltd Recent Developments/Updates
6.2 Emcure Pharmaceuticals Ltd
6.2.1 Emcure Pharmaceuticals Ltd Company Information
6.2.2 Emcure Pharmaceuticals Ltd Description and Business Overview
6.2.3 Emcure Pharmaceuticals Ltd Pharmaceutical Grade Eribulin Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Emcure Pharmaceuticals Ltd Pharmaceutical Grade Eribulin Mesylate Product Portfolio
6.2.5 Emcure Pharmaceuticals Ltd Recent Developments/Updates
6.3 Dr Reddys Laboratories Ltd
6.3.1 Dr Reddys Laboratories Ltd Company Information
6.3.2 Dr Reddys Laboratories Ltd Description and Business Overview
6.3.3 Dr Reddys Laboratories Ltd Pharmaceutical Grade Eribulin Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Dr Reddys Laboratories Ltd Pharmaceutical Grade Eribulin Mesylate Product Portfolio
6.3.5 Dr Reddys Laboratories Ltd Recent Developments/Updates
6.4 Wisdom Pharmaceutical Co Ltd
6.4.1 Wisdom Pharmaceutical Co Ltd Company Information
6.4.2 Wisdom Pharmaceutical Co Ltd Description and Business Overview
6.4.3 Wisdom Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Wisdom Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product Portfolio
6.4.5 Wisdom Pharmaceutical Co Ltd Recent Developments/Updates
6.5 Formosa Laboratories Inc
6.5.1 Formosa Laboratories Inc Company Information
6.5.2 Formosa Laboratories Inc Description and Business Overview
6.5.3 Formosa Laboratories Inc Pharmaceutical Grade Eribulin Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Formosa Laboratories Inc Pharmaceutical Grade Eribulin Mesylate Product Portfolio
6.5.5 Formosa Laboratories Inc Recent Developments/Updates
6.6 Eurofins Cdmo Alphora Inc
6.6.1 Eurofins Cdmo Alphora Inc Company Information
6.6.2 Eurofins Cdmo Alphora Inc Description and Business Overview
6.6.3 Eurofins Cdmo Alphora Inc Pharmaceutical Grade Eribulin Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eurofins Cdmo Alphora Inc Pharmaceutical Grade Eribulin Mesylate Product Portfolio
6.6.5 Eurofins Cdmo Alphora Inc Recent Developments/Updates
6.7 Xiling Lab Co Ltd
6.7.1 Xiling Lab Co Ltd Company Information
6.7.2 Xiling Lab Co Ltd Description and Business Overview
6.7.3 Xiling Lab Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Xiling Lab Co Ltd Pharmaceutical Grade Eribulin Mesylate Product Portfolio
6.7.5 Xiling Lab Co Ltd Recent Developments/Updates
6.8 Chongqing Sintaho Pharmaceutical Co Ltd
6.8.1 Chongqing Sintaho Pharmaceutical Co Ltd Company Information
6.8.2 Chongqing Sintaho Pharmaceutical Co Ltd Description and Business Overview
6.8.3 Chongqing Sintaho Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Chongqing Sintaho Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product Portfolio
6.8.5 Chongqing Sintaho Pharmaceutical Co Ltd Recent Developments/Updates
6.9 Lianyungang Runzhong Pharmaceutical Co Ltd
6.9.1 Lianyungang Runzhong Pharmaceutical Co Ltd Company Information
6.9.2 Lianyungang Runzhong Pharmaceutical Co Ltd Description and Business Overview
6.9.3 Lianyungang Runzhong Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lianyungang Runzhong Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product Portfolio
6.9.5 Lianyungang Runzhong Pharmaceutical Co Ltd Recent Developments/Updates
6.10 Zhejiang Raybow Pharmaceutical Co Ltd
6.10.1 Zhejiang Raybow Pharmaceutical Co Ltd Company Information
6.10.2 Zhejiang Raybow Pharmaceutical Co Ltd Description and Business Overview
6.10.3 Zhejiang Raybow Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Zhejiang Raybow Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product Portfolio
6.10.5 Zhejiang Raybow Pharmaceutical Co Ltd Recent Developments/Updates
6.11 Brightgene Bio-Medical Technology Co Ltd
6.11.1 Brightgene Bio-Medical Technology Co Ltd Company Information
6.11.2 Brightgene Bio-Medical Technology Co Ltd Description and Business Overview
6.11.3 Brightgene Bio-Medical Technology Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Brightgene Bio-Medical Technology Co Ltd Pharmaceutical Grade Eribulin Mesylate Product Portfolio
6.11.5 Brightgene Bio-Medical Technology Co Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Grade Eribulin Mesylate Industry Chain Analysis
7.2 Pharmaceutical Grade Eribulin Mesylate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Grade Eribulin Mesylate Production Mode & Process Analysis
7.4 Pharmaceutical Grade Eribulin Mesylate Sales and Marketing
7.4.1 Pharmaceutical Grade Eribulin Mesylate Sales Channels
7.4.2 Pharmaceutical Grade Eribulin Mesylate Distributors
7.5 Pharmaceutical Grade Eribulin Mesylate Customer Analysis
8 Pharmaceutical Grade Eribulin Mesylate Market Dynamics
8.1 Pharmaceutical Grade Eribulin Mesylate Industry Trends
8.2 Pharmaceutical Grade Eribulin Mesylate Market Drivers
8.3 Pharmaceutical Grade Eribulin Mesylate Market Challenges
8.4 Pharmaceutical Grade Eribulin Mesylate Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Natco Pharma Ltd
Emcure Pharmaceuticals Ltd.
Dr. Reddys Laboratories Ltd.
Wisdom Pharmaceutical Co., Ltd.
Formosa Laboratories, Inc
Brightgene Bio-Medical Technology Co Ltd
Eurofins Cdmo Alphora Inc
Xiling Lab Co Ltd
Chongqing Sintaho Pharmaceutical Co Ltd
Lianyungang Runzhong Pharmaceutical Co Ltd
Zhejiang Raybow Pharmaceutical Co Ltd
List of Tables
 Table 1. Global Pharmaceutical Grade Eribulin Mesylate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pharmaceutical Grade Eribulin Mesylate Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pharmaceutical Grade Eribulin Mesylate Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pharmaceutical Grade Eribulin Mesylate Sales (Tons) of Key Manufacturers (2020-2025)
 Table 5. Global Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pharmaceutical Grade Eribulin Mesylate Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pharmaceutical Grade Eribulin Mesylate Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pharmaceutical Grade Eribulin Mesylate Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pharmaceutical Grade Eribulin Mesylate, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pharmaceutical Grade Eribulin Mesylate, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pharmaceutical Grade Eribulin Mesylate, Product Type & Application
 Table 12. Global Key Manufacturers of Pharmaceutical Grade Eribulin Mesylate, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pharmaceutical Grade Eribulin Mesylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Eribulin Mesylate as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pharmaceutical Grade Eribulin Mesylate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pharmaceutical Grade Eribulin Mesylate Sales by Region (2020-2025) & (Tons)
 Table 18. Global Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Region (2020-2025)
 Table 19. Global Pharmaceutical Grade Eribulin Mesylate Sales by Region (2026-2031) & (Tons)
 Table 20. Global Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Region (2026-2031)
 Table 21. Global Pharmaceutical Grade Eribulin Mesylate Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Region (2020-2025)
 Table 23. Global Pharmaceutical Grade Eribulin Mesylate Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Region (2026-2031)
 Table 25. North America Pharmaceutical Grade Eribulin Mesylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pharmaceutical Grade Eribulin Mesylate Sales by Country (2020-2025) & (Tons)
 Table 27. North America Pharmaceutical Grade Eribulin Mesylate Sales by Country (2026-2031) & (Tons)
 Table 28. North America Pharmaceutical Grade Eribulin Mesylate Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pharmaceutical Grade Eribulin Mesylate Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pharmaceutical Grade Eribulin Mesylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pharmaceutical Grade Eribulin Mesylate Sales by Country (2020-2025) & (Tons)
 Table 32. Europe Pharmaceutical Grade Eribulin Mesylate Sales by Country (2026-2031) & (Tons)
 Table 33. Europe Pharmaceutical Grade Eribulin Mesylate Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pharmaceutical Grade Eribulin Mesylate Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pharmaceutical Grade Eribulin Mesylate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pharmaceutical Grade Eribulin Mesylate Sales by Region (2020-2025) & (Tons)
 Table 37. Asia Pacific Pharmaceutical Grade Eribulin Mesylate Sales by Region (2026-2031) & (Tons)
 Table 38. Asia Pacific Pharmaceutical Grade Eribulin Mesylate Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pharmaceutical Grade Eribulin Mesylate Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharmaceutical Grade Eribulin Mesylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pharmaceutical Grade Eribulin Mesylate Sales by Country (2020-2025) & (Tons)
 Table 42. Latin America Pharmaceutical Grade Eribulin Mesylate Sales by Country (2026-2031) & (Tons)
 Table 43. Latin America Pharmaceutical Grade Eribulin Mesylate Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pharmaceutical Grade Eribulin Mesylate Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pharmaceutical Grade Eribulin Mesylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pharmaceutical Grade Eribulin Mesylate Sales by Country (2020-2025) & (Tons)
 Table 47. Middle East and Africa Pharmaceutical Grade Eribulin Mesylate Sales by Country (2026-2031) & (Tons)
 Table 48. Middle East and Africa Pharmaceutical Grade Eribulin Mesylate Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pharmaceutical Grade Eribulin Mesylate Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pharmaceutical Grade Eribulin Mesylate Sales (Tons) by Type (2020-2025)
 Table 51. Global Pharmaceutical Grade Eribulin Mesylate Sales (Tons) by Type (2026-2031)
 Table 52. Global Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Type (2020-2025)
 Table 53. Global Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Type (2026-2031)
 Table 54. Global Pharmaceutical Grade Eribulin Mesylate Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pharmaceutical Grade Eribulin Mesylate Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Type (2020-2025)
 Table 57. Global Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Type (2026-2031)
 Table 58. Global Pharmaceutical Grade Eribulin Mesylate Price (US$/Kg) by Type (2020-2025)
 Table 59. Global Pharmaceutical Grade Eribulin Mesylate Price (US$/Kg) by Type (2026-2031)
 Table 60. Global Pharmaceutical Grade Eribulin Mesylate Sales (Tons) by Application (2020-2025)
 Table 61. Global Pharmaceutical Grade Eribulin Mesylate Sales (Tons) by Application (2026-2031)
 Table 62. Global Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Application (2020-2025)
 Table 63. Global Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Application (2026-2031)
 Table 64. Global Pharmaceutical Grade Eribulin Mesylate Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pharmaceutical Grade Eribulin Mesylate Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Application (2020-2025)
 Table 67. Global Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Application (2026-2031)
 Table 68. Global Pharmaceutical Grade Eribulin Mesylate Price (US$/Kg) by Application (2020-2025)
 Table 69. Global Pharmaceutical Grade Eribulin Mesylate Price (US$/Kg) by Application (2026-2031)
 Table 70. Natco Pharma Ltd Company Information
 Table 71. Natco Pharma Ltd Description and Business Overview
 Table 72. Natco Pharma Ltd Pharmaceutical Grade Eribulin Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Natco Pharma Ltd Pharmaceutical Grade Eribulin Mesylate Product
 Table 74. Natco Pharma Ltd Recent Developments/Updates
 Table 75. Emcure Pharmaceuticals Ltd Company Information
 Table 76. Emcure Pharmaceuticals Ltd Description and Business Overview
 Table 77. Emcure Pharmaceuticals Ltd Pharmaceutical Grade Eribulin Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. Emcure Pharmaceuticals Ltd Pharmaceutical Grade Eribulin Mesylate Product
 Table 79. Emcure Pharmaceuticals Ltd Recent Developments/Updates
 Table 80. Dr Reddys Laboratories Ltd Company Information
 Table 81. Dr Reddys Laboratories Ltd Description and Business Overview
 Table 82. Dr Reddys Laboratories Ltd Pharmaceutical Grade Eribulin Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Dr Reddys Laboratories Ltd Pharmaceutical Grade Eribulin Mesylate Product
 Table 84. Dr Reddys Laboratories Ltd Recent Developments/Updates
 Table 85. Wisdom Pharmaceutical Co Ltd Company Information
 Table 86. Wisdom Pharmaceutical Co Ltd Description and Business Overview
 Table 87. Wisdom Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Wisdom Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product
 Table 89. Wisdom Pharmaceutical Co Ltd Recent Developments/Updates
 Table 90. Formosa Laboratories Inc Company Information
 Table 91. Formosa Laboratories Inc Description and Business Overview
 Table 92. Formosa Laboratories Inc Pharmaceutical Grade Eribulin Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Formosa Laboratories Inc Pharmaceutical Grade Eribulin Mesylate Product
 Table 94. Formosa Laboratories Inc Recent Developments/Updates
 Table 95. Eurofins Cdmo Alphora Inc Company Information
 Table 96. Eurofins Cdmo Alphora Inc Description and Business Overview
 Table 97. Eurofins Cdmo Alphora Inc Pharmaceutical Grade Eribulin Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Eurofins Cdmo Alphora Inc Pharmaceutical Grade Eribulin Mesylate Product
 Table 99. Eurofins Cdmo Alphora Inc Recent Developments/Updates
 Table 100. Xiling Lab Co Ltd Company Information
 Table 101. Xiling Lab Co Ltd Description and Business Overview
 Table 102. Xiling Lab Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Xiling Lab Co Ltd Pharmaceutical Grade Eribulin Mesylate Product
 Table 104. Xiling Lab Co Ltd Recent Developments/Updates
 Table 105. Chongqing Sintaho Pharmaceutical Co Ltd Company Information
 Table 106. Chongqing Sintaho Pharmaceutical Co Ltd Description and Business Overview
 Table 107. Chongqing Sintaho Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Chongqing Sintaho Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product
 Table 109. Chongqing Sintaho Pharmaceutical Co Ltd Recent Developments/Updates
 Table 110. Lianyungang Runzhong Pharmaceutical Co Ltd Company Information
 Table 111. Lianyungang Runzhong Pharmaceutical Co Ltd Description and Business Overview
 Table 112. Lianyungang Runzhong Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. Lianyungang Runzhong Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product
 Table 114. Lianyungang Runzhong Pharmaceutical Co Ltd Recent Developments/Updates
 Table 115. Zhejiang Raybow Pharmaceutical Co Ltd Company Information
 Table 116. Zhejiang Raybow Pharmaceutical Co Ltd Description and Business Overview
 Table 117. Zhejiang Raybow Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 118. Zhejiang Raybow Pharmaceutical Co Ltd Pharmaceutical Grade Eribulin Mesylate Product
 Table 119. Zhejiang Raybow Pharmaceutical Co Ltd Recent Developments/Updates
 Table 120. Brightgene Bio-Medical Technology Co Ltd Company Information
 Table 121. Brightgene Bio-Medical Technology Co Ltd Description and Business Overview
 Table 122. Brightgene Bio-Medical Technology Co Ltd Pharmaceutical Grade Eribulin Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 123. Brightgene Bio-Medical Technology Co Ltd Pharmaceutical Grade Eribulin Mesylate Product
 Table 124. Brightgene Bio-Medical Technology Co Ltd Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Pharmaceutical Grade Eribulin Mesylate Distributors List
 Table 128. Pharmaceutical Grade Eribulin Mesylate Customers List
 Table 129. Pharmaceutical Grade Eribulin Mesylate Market Trends
 Table 130. Pharmaceutical Grade Eribulin Mesylate Market Drivers
 Table 131. Pharmaceutical Grade Eribulin Mesylate Market Challenges
 Table 132. Pharmaceutical Grade Eribulin Mesylate Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pharmaceutical Grade Eribulin Mesylate
 Figure 2. Global Pharmaceutical Grade Eribulin Mesylate Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceutical Grade Eribulin Mesylate Market Share by Type: 2024 & 2031
 Figure 4. Purity≥99% Product Picture
 Figure 5. Purity<99% Product Picture
 Figure 6. Global Pharmaceutical Grade Eribulin Mesylate Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharmaceutical Grade Eribulin Mesylate Market Share by Application: 2024 & 2031
 Figure 8. Solution
 Figure 9. Others
 Figure 10. Global Pharmaceutical Grade Eribulin Mesylate Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pharmaceutical Grade Eribulin Mesylate Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Pharmaceutical Grade Eribulin Mesylate Sales (2020-2031) & (Tons)
 Figure 13. Global Pharmaceutical Grade Eribulin Mesylate Average Price (US$/Kg) & (2020-2031)
 Figure 14. Pharmaceutical Grade Eribulin Mesylate Report Years Considered
 Figure 15. Pharmaceutical Grade Eribulin Mesylate Sales Share by Manufacturers in 2024
 Figure 16. Global Pharmaceutical Grade Eribulin Mesylate Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Pharmaceutical Grade Eribulin Mesylate Players: Market Share by Revenue in Pharmaceutical Grade Eribulin Mesylate in 2024
 Figure 18. Pharmaceutical Grade Eribulin Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Pharmaceutical Grade Eribulin Mesylate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Country (2020-2031)
 Figure 21. North America Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Country (2020-2031)
 Figure 22. United States Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Country (2020-2031)
 Figure 25. Europe Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Region (2020-2031)
 Figure 33. China Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Pharmaceutical Grade Eribulin Mesylate Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Pharmaceutical Grade Eribulin Mesylate Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Pharmaceutical Grade Eribulin Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Pharmaceutical Grade Eribulin Mesylate by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Pharmaceutical Grade Eribulin Mesylate by Type (2020-2031)
 Figure 52. Global Pharmaceutical Grade Eribulin Mesylate Price (US$/Kg) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Pharmaceutical Grade Eribulin Mesylate by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Pharmaceutical Grade Eribulin Mesylate by Application (2020-2031)
 Figure 55. Global Pharmaceutical Grade Eribulin Mesylate Price (US$/Kg) by Application (2020-2031)
 Figure 56. Pharmaceutical Grade Eribulin Mesylate Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions